Rational treatment of anemias in malignant diseases.
D000230:Adenocarcinoma / Q000150:complications; D000368:Aged; D000740:Anemia / Q000150:complications / Q000628:therapy*; D000744:Anemia, Hemolytic, Autoimmune / Q000150:complications; D000747:Anemia, Hypochromic / Q000150:complications / Q000628:therapy; D000748:Anemia, Macrocytic / Q000150:complications; D000750:Anemia, Myelophthisic / Q000150:complications / Q000628:therapy; D000756:Anemia, Sideroblastic / Q000150:complications; D001859:Bone Neoplasms / Q000150:complications; D002430:Cecal Neoplasms / Q000150:complications; D003536:Cystadenocarcinoma / Q000150:complications; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000150:complications*; D010051:Ovarian Neoplasms / Q000150:complications; D011471:Prostatic Neoplasms / Q000150:complications